Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
407
-
Total 13F shares, excl. options
-
89.4M
-
Shares change
-
-1.9M
-
Total reported value, excl. options
-
$11.1B
-
Value change
-
-$287M
-
Put/Call ratio
-
0.94
-
Number of buys
-
232
-
Number of sells
-
-155
-
Price
-
$124.19
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q2 2021
498 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q2 2021.
Guardant Health, Inc. - Common Stock (GH) has 407 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89.4M shares
of 124M outstanding shares and own 72.22% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.63M shares), FMR LLC (5.64M shares), BlackRock Inc. (5.53M shares), VIKING GLOBAL INVESTORS LP (4.26M shares), MORGAN STANLEY (4.25M shares), Clearbridge Investments, LLC (3.4M shares), FRED ALGER MANAGEMENT, LLC (2.8M shares), COATUE MANAGEMENT LLC (2.66M shares), Capital Research Global Investors (2.16M shares), and Nuveen Asset Management, LLC (2.13M shares).
This table shows the top 407 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.